Background. Several studies indicate that heart transplantation (HTx) is associated with depression and reduced quality of life. However, the impact of depression on the prognosis for HTx-patients has not yet been sufficiently established. The aim of the present study was to prospectively investigate the influence of depression on mortality in patients with HTx, adjusting for other known risk factors. Methods. In a prospective, cross-sectional study with minimum 5-year follow-up, symptoms of depression were assessed in 147 HTx-patients using the Beck Depression Inventory (BDI). Results. Mild to severe depressive symptoms (BDI Ն10) were observed in 36 patients (24.5%). Depressive symptoms on inclusion increased the risk of mortality during the follow-up period. The risk remained significant after adjusting for several somatic and lifestyle risk factors, and the adjusted relative risk associated with depression (risk ratio: 2.32; 95% CI: 1.13-4.79; Pϭ0.02) was comparable to the adjusted relative risk associated with time since HTx. Conclusions. Symptoms of depression predict mortality independently of somatic and lifestyle risk factors in HTx patients, and this group of patients should be screened for depressive symptoms.
H eart transplantation (HTx) is an acceptable procedure for patients with chronic heart failure (HF) when maximal medical and surgical treatment is no longer effective. Data from the Registry of the International Society for Heart and Lung Transplantation indicate that, after a steep decrease in survival during the first 6 months (85%), there is a linear decrease in survival of approximately 3.4% per year, with a median survival time of 9 years (1). Several factors associated with mortality in HTx patients have been identified, such as recipient and donor age, body mass index, previous transplantations, etiology of HF, impaired renal function, early appearance of allograft vasculopathy, and number of rejections, even though the evidence for some of these factors is conflicting and changing over time (1) . Few studies, however, have focused on the role of psychosocial factors in survival among HTx patients. This is somewhat surprising because social and psychological factors have been studied quite extensively in patients with cardiovascular disease (CVD) (2) (3) (4) . In the research literature, elevated depressive symptoms appear to be a robust risk factor and prognostic marker of CVD and all-cause mortality, both among populations of initially healthy individuals (3) and among those with known CVD (5, 6) .
The majority of the prognostic studies in this field have addressed depression as a risk factor in patients with myocardial infarction (MI) (6, 7) , but samples of patients with coronary artery graft surgery and percutaneous transluminal coronary angioplasty have also been included (8 -10) , as well as patients with HF (11) (12) (13) (14) . Depression has also been related to the progression of subclinical coronary atherosclerosis (15) (16) (17) , although with some conflicting findings (18 -20) .
There is a growing body of research on psychosocial factors in patients who have undergone HTx (21) . Findings indicate high prevalence rates for moderate and severe levels of depression in the waiting period (22) , in the first year after successful HTx (23) , and on long-term follow-up (24, 25) . Earlier studies have reported that coping styles and social support may be significant predictors of morbidity and mortality in patients awaiting HTx (26, 27) and also after successful HTx (28 -30) . To the best of our knowledge, only two studies have reported on the effect of depression on survival after HTx. Zipfel and colleagues found that preoperative depression predicted all-cause mortality in a small subgroup of HTx patients with ischemic but not dilated cardiomyopathy (31) . Furthermore, a composite score of retrospectively coded psychiatric risk factors, including depression-related diagnoses, predicted overall mortality in HTx patients (32) . Both studies had a small sample size and neither included both lifestyle and medical risk factors as baseline covariates.
The possible association between depression and mortality in HTx patients needs to be replicated in prospective studies with lager samples, and the association between depression and mortality should control for alternative, and possibly competing, risk factors. The aim of this study was therefore to investigate the influence of depression on allcause mortality in HTx patients, adjusting for other relevant risk factors.
tine postHTx management at Rikshospitalet Medical Center, Oslo, Norway, during the period from November 1998 to March 2000. Rikshospitalet Medical Center has the national responsibility for the follow-up of all HTx patients in Norway.
The patients were contacted consecutively by a research nurse (A.R., M.H.) during the annual medical evaluation and informed about the study. Those consenting to participate filled in questionnaires about psychological symptoms and quality of life. The questionnaires were answered in a setting without family members or hospital staff present. Data regarding recipient age, sex, marital status, smoking, immunosuppressive drug regimen, time since transplantation, body mass index, renal function, and transplant coronary artery disease were collected from the medical records or the hospital transplant database.
All patients received immunosuppressive therapy as per local protocol. This consisted of maintenance therapy with prednisolone, cyclosporine or tacrolimus, and azathioprine or mycophenolate mofetil. No cytotoxic induction therapy was given and a statin was introduced in all patients undergoing HTx from 1997 onwards. Prednisolone was commenced immediately following HTx and was weaned off by 0.25 mg at every negative endomyocardial biopsy performed during the first year postHTx to a maintenance dose of 0.1 mg/kg.
The research protocol was approved by the Regional Committee for Medical Research Ethics, Southern Norway, and written informed consent was obtained.
Variables
To adjust for disease severity and other possible baseline confounders, a number of variables were included as covariates. These variables were selected because previous research has found them to be associated with mortality in cardiac disease or that they otherwise could be expected to be related to disease severity. If no established cutoff value was available for the continuous covariates, the median value was used as cutoff in the survival analyses: sex; marital status; age (median cutoff Ͼ57 years); time since HTx (TimeHTx, median cutoff Ͼ5 years); smoking (1ϭno, 2ϭyes) based on self-report, nurses' report or hospital medical records; and body mass index defined as kg/m 2 (cutoff Ͼ25 corresponding to the World Health Organization's grade 1 overweight [33] ). Self-rated weight (1ϭat ideal weight or below, 2ϭabove ideal weight) was based on questionnaire data, whereas self-rated physical health was assessed with Physical Functioning (PF), the 10-item subscale from Short Form (SF)-36 (34) measuring self-rated limitations in performing physical activities due to health ranging from low (100ϭno limitations due to health) to high (0ϭgreatly limited in performing all physical activities; median cutoff Յ85). Reliability estimated as Cronbach's alpha was 0.92 in the present sample.
Serum creatinine at inclusion was used to calculate the estimated glomerular filtration rate (GFR) according to the Modification of Diet in Renal Disease Study formula (35) . Estimated GFR was categorized according to the National Kidney Foundation Disease Outcomes Quality Initiative Guidelines, which classify GFR Ͻ60 mL/min/1.73 m 2 as severe to moderate reduction (36) . These guidelines define GFR between 60 and 89 mL/min/1.73 m 2 as renal impairment only when albuminuria or abnormalities on kidney biopsy or imaging is present. Since the present study did not have such data available, we defined GFR Ն60 mL/min/1.73 m 2 as conservatively "normal" renal function.
The diagnosis of transplant coronary artery disease (TCAD) (1ϭno, 2ϭyes) was defined as luminal narrowing in one or more of the main arteries based on the presence of any of the following: any degree of stenosis, distal tapering/pruning, or loss of tertiary vessels. The angiography films were assessed by two experienced independent invasive cardiologists without knowledge of the patients' psychological status.
Symptoms of depression were assessed using the 21-item Beck Depression Inventory (BDI), a well-established tool (37) . Reliability estimated by Cronbach's alpha was 0.86 in the present sample. In line with previous research, the following cutoff values were used: mild symptoms Ն10, moderate symptoms Ն16, and severe symptoms Ն24.
Survival status, time of death, and cause of death were obtained from the hospital records in March to October 2005, for a minimum follow-up of 5 years after inclusion.
Statistical Analyses
The Kaplan-Meier method was used to calculated survival curves and the log-rank 2 test to test differences in survival. Cox proportional hazards regression analysis was used to estimate unadjusted and adjusted relative risks of mortality associated with BDI and the covariates. In the analysis of adjusted relative risks, BDI was entered in the first block, whereas all covariates were entered in the second block. A Wald backward stepwise regression procedure (exit criterion P Ͼ0.05) was used to test which of the predictors had an independent association with mortality. All predictors were dichotomized, and the contrast in relative risk between categories (high vs. low) was based on a simple contrast model, with the low category as the reference. The relative risk (RR) indicates the risk of mortality for individuals within the high category compared to those in the low category, and 95% confidence intervals (95% CI) for the RR are reported. In all analyses, missing values were replaced by the mean value for the individual variable (the number of persons with missing data ranged from 0 to 9 for the variables included). All analyses were done using SPSS version 13/PC software.
The authors had full access to the data and take responsibility for its integrity. All authors have read and agreed to the manuscript as written.
RESULTS

Study Sample
Of the total population of 220 HTx patients attending their annual examination, 147 (66.8%) were included. The main reasons for not participating were not having the energy to fill in the questionnaires, not interested in participating, or having other serious diseases such as cancer. Average age on inclusion was 53.4 years with a wide range ( Table 1) . Three-quarters were males and the majority was married or cohabitant. More than half of the sample had a disability pension and fewer than one in five were in employment. On average, the participants were included 5.6 years after the HTx.
On inclusion, one-quarter had evidence of TCAD, the average level of GFR was 60.8 mL/min/1.73 m 2 and half of the sample had at least moderate renal impairment (Table 3) . Half of the sample had a body mass index higher than 25 and close to two-thirds rated their weight as above ideal. Furthermore, one in five smoked, and the average score on SF-36 Physical Functioning was 78.4, which is significantly lower than the average of 85.2 in the Norwegian norm sample (PϽ0.001). Based on information from the medical records and the contact physician, none of the patients was receiving treatment for depression at the time of inclusion.
Follow-Up
No patients were lost to follow-up, and the mean postinclusion survival was 6.0Ϯ0.3 years. A total of 39 (26.5%) patients died during the follow-up period ( Table 1) . Causes of death were cancer (nϭ13), chronic rejection/graft sclerosis (nϭ9), acute rejection (nϭ2), infection (nϭ2), and other (nϭ10). The cause of death was unknown for three patients who lived abroad at the time of death.
Depression
The average score on BDI was 7.4Ϯ6.5, with 36 (24.5%) patients reporting some symptoms of depression. Of these, 20 (13.6%), 9 (6.1%), and 7 (4.8%) had a BDI score representing mild (Ն10), moderate (Ն16), and severe symptoms of depression (Ն24), respectively.
Baseline Intercorrelations for BDI and Covariates
Pearson correlations for the continuous version of the baseline variables are presented in Table 2 . BDI mainly had low and insignificant correlations with the included covariates, but higher levels of depression were moderately associated with being a smoker and strongly associated with limitations in physical functioning due to health problems. It is worth noting that depression was not associated with TCAD and GFR. On the other hand, TCAD was associated with age and time since HTx, whereas self-rated limitation in physical functioning (SF-36 PF) was associated with all the other covariates except smoking. Figure 1 illustrates the course of postHTx survival in patients with no (BDI Ͻ10), mild (BDI 10 -15), and moderate/ severe (BDI Ն16) symptoms of depression at baseline. A Kaplan-Meier survival analysis indicated that the survival outcome was significantly different among the three depression subgroups (log-rank The simple associations based on log-rank tests and the unadjusted relative risks of mortality for depression and the covariates are summarized in Table 3 . Higher level of depressive symptoms (BDI Ն10) was associated with an almost threefold increase in the risk of mortality.
Depressive Symptoms and Mortality: Simple Associations and Unadjusted Relative Risk
As expected, age, time since HTx, TCAD, and GFR predicted mortality, as well as the indicators of overweight and physical limitations due to health. Being a smoker at baseline showed only a marginal association with mortality during follow-up (Pϭ0.06). However, as smoking and depression were interrelated at baseline (Table 2) , smoking was maintained as a covariate in the multivariate analyses. Gender (log rank 2 : 0.00, Pϭ0.97) and marital status (log rank 2 : 2.29, Pϭ0.13) were unrelated to mortality, and not included in the table.
Depression and Relative Risk of Mortality Adjusted for Baseline Covariates
The main findings from the multivariate analyses are summarized in Table 4 . In the complete model comprising all covariates, symptoms of depression at baseline were associated with increased risk of mortality (RR: 2.32; 95% CI: 1.13-4.79; Pϭ0.02) after controlling for relevant biomedical and lifestyle-related covariates.
In the Wald backward stepwise regression analysis, SF-36 PF, body mass index, smoking, age, and TCAD were excluded from the model (exit criterion P Ͼ0.05). Symptoms of depression remained in the model that otherwise included time since HTx, indication of renal impairment, and selfrated weight above ideal. 
DISCUSSION
The main finding in the present study was that symptoms of depression are common following HTx and that it is an important independent risk factor for all-cause mortality during a 6-year follow-up period.
Several other baseline risk factors such as age, time since HTx, TACD, GFR, overweight, and physical limitation due to health problems were, as expected, associated with reduced survival time. The inclusion of these risk factors as confounding variables in the multivariate analyses did not, however, explain the association between depression and mortality. Thus, the association was not mediated by the medical and lifestyle factors included in the present study. It should also be noted that the correlations between symptoms of depression and the more biologically based risk factors were close to zero, indicating that the level of depression was not mainly a reflection of disease severity. The findings indicate that the reporting of depressive symptoms reflects actual depression rather than somatic complaints or lack of vitality originating from the heart condition itself. In general, these findings are consistent with the previous studies of depression and prognosis in HTx patients (31, 32) . In contrast to the two previous studies, the association between depressive symptoms and mortality in the present study was not restricted to a subsample of patients (31) and depressive symptoms were assessed at the time of inclusion and not retrospectively (32) . These two aspects and the larger sample add to the generalizability of the present findings.
A reciprocal relationship between depression and smoking is well established in both cardiac patients and community samples (38) , and depression and smoking were also significantly intercorrelated in the present sample. It should be noted, however, that the association between depression and mortality was not a confounding effect of smoking, as depression was retained as an independent predictor after (2, 39) . However, depression may be related to other lifestyle factors, such as diet, not included in the present study.
In the present study, the patients were followed over a mean of 6 years. As can be seen from Figure 1 , the main effect of depression on mortality was not present until after quite some time. Chi-square analyses indicate that the differences in crude mortality rate for low vs. high levels of depressive symptoms reached a statistically significant level in the fourth year (10.8% vs. 25.0%, 2 ϭ4.47, dfϭ1, Pϭ0.03). This is in line with findings from studies of patients with HF that show that depression has no prognostic value within an observational period of 1 year or less (12, 13, 40, 41) .
In recent years, an increasing number of studies have addressed the mechanisms that may underlie the relationship between depression and the development of cardiovascular disease and subsequent increased mortality. Among the possible candidates, the following have been suggested and have received some empirical support: clustering of depression together with other risk factors, such as smoking, diet, obesity, hypertension and diabetes (38, 42) ; hypothalamic-pituitaryadrenalin axis hyperactivity and increased cortisol level (43) ; elevated levels of proinflammatory cytokines leading to atherosclerosis; platelet activation and hypercoagulability (44) ; and noncompliance with cardiac rehabilitation and medical regimens (45) . As expected, there was a variety of different causes of death in the present sample, but the subgroups were too small for meaningful analyses. Therefore, it remains an open question whether depression is related to increased mortality through nonspecific mechanisms, such as diet or reduced compliance, or through specific biological pathogenic pathways.
Given the impact of depression on quality of life and its relationship to survival in different groups of cardiac patients, the screening and treatment of depression in these patients should be improved. Screening and subsequent diagnostic evaluation with a view to identifying depressive syndromes and instigating adequate treatment should probably be done on a routine basis in both the pre-and postHTx phase. The present study and other studies indicate that depressive symptoms are easily identifiable in cardiac patients (46) . It is also well documented that depressive symptoms are modifiable by pharmacological (47) and psychological treatment (48) . The fact that none of the included patients were receiving treatment for depression underlines the need for systematic screening and assessment.
In the screening of cardiac patients for depression, it should be noted that the present and other studies indicate that the critical prognostic cutoff is not a clinical diagnosis of a full major depressive disorder, but a moderate elevation of self-reported depressive symptoms (7, 8, 10, 13, 14, 49) . Further research comparing the prognostic value of self-reported depressive symptoms and clinical, interview-based diagnoses is needed.
The limitations of the present study deserve mention. This study was carried out on a cross-sectional sample that necessitated the assessment of depressive symptoms at different points of time after the HTx. Because time since the HTx is a risk factor in itself, one cannot exclude the possibility that the time elapsed from the HTx to the assessment of depressive symptoms is confounded by some indicators of the medical condition or severity that were not included in the present study. On the other hand, assessing depression before the HTx would not eliminate the problems related to cross-sectional inclusion completely, since the disease processes necessitating a HTx are heterogeneous and could be expected to influence the reporting of preHTx depressive symptoms as much as the medical conditions after the HTx.
Even though the present study sample was larger than in the two previous studies of HTx patients, the power to detect and adjust for small effects is obviously limited.
Finally, one third of the eligible patients refused to participate. Even though the mortality rate among those not participating was identical to the study group, one cannot exclude the possibility that not participating was associated with some factor that may have biased the findings.
CONCLUSIONS
From a clinical point of view, these data support the need for systematic screening for depression in HTx patients. Because the negative effects of depression seem to evolve slowly, there may be sufficient time to initiate treatment. The findings also indicate that continuous attention to depressive symptoms is required. Additional research is needed to learn more about the active mechanisms behind the relationship that was observed and their implication for treatment.
